Catalyst Pharmaceuticals filed a disclosure with the Securities and Exchange Commission on June 15, 2026.
1 report, 1 independent
Updated Jun 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Catalyst Pharmaceuticals filed a disclosure with the Securities and Exchange Commission on June 15, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Catalyst Pharmaceuticals
company in Coral Gables, United States
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- C3.ai filed disclosures with the Securities and Exchange Commission on June 18, 2026.
- Eli Lilly and Company filed a disclosure with the Securities and Exchange Commission on June 15, 2026.
- Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.